文献速递其他结缔组织病

内皮间质转化参与系统性硬化症内皮功能障碍与皮肤纤维化

Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
PubMed 文献 · Ann Rheum Dis · 2017-01-06

该研究探讨内皮间质转化(EndoMT)在系统性硬化症(SSc)皮肤纤维化中的作用。在SSc患者及博来霉素诱导和uPAR缺陷小鼠模型的皮肤血管中均检测到EndoMT中间态细胞;SSc来源真皮微血管内皮细胞呈现肌纤维母细胞样特征并高表达Snail1,且SSc血清或TGFβ1可诱导健康内皮细胞发生EndoMT,提示EndoMT可能是连接内皮功能障碍与皮肤纤维化的关键事件。

要点

  • SSc患者及两种小鼠模型皮肤血管中均存在EndoMT中间态细胞。
  • SSc-dMVECs呈纺锤形,CD31/VE-cadherin降低并表达α-SMA等间质标志。
  • SSc血清或TGFβ1可诱导健康dMVECs发生EndoMT,涉及MMP-12依赖的uPAR切割。

核心结论

  • 在SSc中,EndoMT可能是连接内皮功能障碍与皮肤纤维化发展的关键事件。

研究设计与样本

  • 对SSc患者皮肤切片及博来霉素诱导和uPAR缺陷小鼠模型皮肤切片进行CD31或VE-cadherin与α-SMA免疫染色。
  • 从SSc和健康皮肤分离真皮微血管内皮细胞(SSc-dMVECs和H-dMVECs),并用TGFβ1或SSc/健康血清处理H-dMVECs。
  • 通过实时PCR、免疫印迹和免疫荧光评估内皮/间质标志,用胶原凝胶收缩实验检测细胞收缩表型。

主要发现

  • 在SSc患者以及博来霉素诱导和uPAR缺陷小鼠模型的皮肤血管中鉴定出EndoMT中间阶段细胞。
  • 与H-dMVECs不同,SSc-dMVECs呈纺锤形,CD31和VE-cadherin水平降低并与肌纤维母细胞标志(α-SMA+应力纤维、S100A4和I型胶原)共表达。
  • SSc-dMVECs组成性核定位EndoMT驱动因子Snail1,并能有效收缩胶原凝胶。
  • 用SSc血清或TGFβ1处理H-dMVECs可诱导肌纤维母细胞样形态和收缩表型,内皮标志下调并伴随间质标志诱导。
  • 基质金属蛋白酶-12依赖的uPAR切割参与SSc血清诱导的EndoMT。

临床怎么用

  • EndoMT及其驱动因子Snail1可能作为SSc皮肤纤维化的潜在干预靶点。
  • SSc血清可通过MMP-12依赖的uPAR切割诱导EndoMT,提示该通路值得进一步转化研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic sclerosis (SSc) features multiorgan fibrosis orchestrated predominantly by activated myofibroblasts. Endothelial-to-mesenchymal transition (EndoMT) is a transdifferentiation by which endothelial cells (ECs) lose their specific morphology/markers and acquire myofibroblast-like features. Here, we determined the possible contribution of EndoMT to the pathogenesis of dermal fibrosis in SSc and two mouse models. METHODS: Skin sections were immunostained for endothelial CD31 or vascular endothelial (VE)-cadherin in combination with α-smooth muscle actin (α-SMA) myofibroblast marker. Dermal microvascular ECs (dMVECs) were prepared from SSc and healthy skin (SSc-dMVECs and H-dMVECs). H-dMVECs were treated with transforming growth factor-β1 (TGFβ1) or SSc and healthy sera. Endothelial/mesenchymal markers were assessed by real-time PCR, immunoblotting and immunofluorescence. Cell contractile phenotype was assayed by collagen gel contraction. RESULTS: Cells in intermediate stages of EndoMT were identified in dermal vessels of either patients with SSc or bleomycin-induced and urokinase-type plasminogen activator receptor (uPAR)-deficient mouse models. At variance with H-dMVECs, SSc-dMVECs exhibited a spindle-shaped appearance, co-expression of lower levels of CD31 and VE-cadherin with myofibroblast markers (α-SMA+ stress fibres, S100A4 and type I collagen), constitutive nuclear localisation of the EndoMT driver Snail1 and an ability to effectively contract collagen gels. Treatment of H-dMVECs either with SSc sera or TGFβ1 resulted in the acquisition of a myofibroblast-like morphology and contractile phenotype and downregulation of endothelial markers in parallel with the induction of mesenchymal markers. Matrix metalloproteinase-12-dependent uPAR cleavage was implicated in the induction of EndoMT by SSc sera. CONCLUSIONS: In SSc, EndoMT may be a crucial event linking endothelial dysfunction and development of dermal fibrosis.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Manetti M, Romano E, Rosa I, et al. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Ann Rheum Dis. 2017. PMID: 28062404. doi:10.1136/annrheumdis-2016-210229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。